Clinical and animal studies of an epilepsy model, where anti-inflammatory drugs such as celecoxib (cyclooxygenase inhibitor), Anakinra (IL-1β antagonist), and minocycline (microglial inhibitor) ameliorated depression, also support this hypothesis14,24–26. This evidence concerns the gene IL1B and depressive symptom measurement.